SEC Form 4 Summary RPRX

Royalty Pharma CFO Terrance P. Coyne Reports $17.69 Million in Sales

Royalty Pharma CFO Terrance P. Coyne sold 257,122 RPRX shares for $17,693,642.13 across five transactions.

Transaction Value:
$17,693,642.13
Shares transacted:
257,122
Average price:
$68.81
Insider:

The Form 4 filing, an SEC report of insider stock trades, was filed on November 18, 2026. The trades took place November 16–17. Terrance P. Coyne serves as executive vice president and chief financial officer of Royalty Pharma (RPRX).

Transaction details

Transaction
Date of Earliest Transaction2026-11-16
Date of Latest Transaction2026-11-17
Buy/Sellsell
Transaction Count5
Shares Transacted257,122
Price$68.81
Total Transaction Value$17,693,642.13
Insider
Ticker SymbolRPRX
CompanyRoyalty Pharma plc
Insider NameCoyne Terrance P.
Insider TitleEVP & CFO
Sector - IndustryHealthcare - Biotechnology
Holdings
Total Shares Owned After Transaction0
Position Size Change100.00%
Filing
Filing Date2026-11-18
SEC LinkView filing

FAQ

What type of transaction is this?

This was a set of five share sales, reported with SEC transaction code S. All five transactions were reported for the same insider in one filing.

What was the average price of the transaction?

The average sale price was $68.81 per share, rounded to cents. This average covers the five transactions. Prices for each separate sale are not available in the transaction details.

How did this transaction affect the insider's holdings?

He sold 257,122 shares, or 100.00% of the shares in the reported balance before the sales. He reported zero shares in that balance afterward. The available details do not show whether he held shares in other accounts or through other forms of ownership.

What's the total transaction value?

The five sales had a total value of $17,693,642.13, rounded to cents. This amount covers all five transactions together.

Are there any special circumstances around this transaction?

The transaction information includes a Rule 10b5-1 trading-plan reference. These plans set trading instructions in advance. Footnote text and plan terms are not available here, so it is unclear whether the reference covers all five sales. The plan's start date and trading schedule are also unknown.

For research purposes only; not investment advice.

Follow the Newswire
Feedly RSS feed
About RSS

Get new articles in your feed reader as they are published. Add our RSS feed to Feedly or another RSS reader.

Instant SEC Form 4 alerts

Get the next insider trade alert in real time.

Follow the filings behind the headlines. Get matching insider trade alerts sent straight to your email or Telegram, with links to the original SEC filings. Choose Premium for instant alert delivery and ticker-level filters.

Try instant alerts free 10 trading days · No credit card required

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
  • 20 years of alert history
  • Live alert directory updates
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and SEC filing links
  • Access to the alert directory hourly refreshes
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

  • Everything in Standard
  • Instant delivery detection-to-outbound time averages 0.60 seconds
  • Alert intervals starting from one minute
  • Real time alert directory updates
Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.